Nanotechnology-based drug delivery to improve the therapeutic benefits of NRF2 modulators in cancer therapy

  1. Sezgin-Bayindir, Z.
  2. Losada-Barreiro, S.
  3. Bravo-Díaz, C.
  4. Sova, M.
  5. Kristl, J.
  6. Saso, L.
Aldizkaria:
Antioxidants

ISSN: 2076-3921

Argitalpen urtea: 2021

Alea: 10

Zenbakia: 5

Mota: Berrikuspena

DOI: 10.3390/ANTIOX10050685 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus